Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon-based PCIA vs morphine for postoperative pain after laparoscopic gastrointestinal surgery
ChiCTR2500112103Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Nov 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hsk21542 in postoperative pain (4 arms), sponsored by Peking University First Hospital. Primary endpoint: Time-weighted sum of pain intensity difference (SPID) of movement-evoked visceral pain within 48 hours. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500112103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112103.